GenVec Gets Conditional License For Foot-And-Mouth Vaccine For Cattle

Date : 06/07/2012 @ 8:56AM
Source : Dow Jones News
Stock : Sanofi (SAN)
Quote : 65.28  -0.32 (-0.49%) @ 11:35AM
Sanofi share price Chart

GenVec Gets Conditional License For Foot-And-Mouth Vaccine For Cattle

Genvec, Inc. (NASDAQ:GNVC)
Historical Stock Chart

5 Years : From Apr 2013 to Apr 2018

Click Here for more Genvec, Inc. Charts.
   By Tess Stynes 

GenVec Inc. (GNVC) said the U.S. Department of Agriculture issued a conditional license for its foot-and-mouth vaccine for use in cattle, representing the biopharmaceutical company's first approved product.

Shares were up 26% at $2.98 in light premarket trading. Through Wednesday's close, the stock is down 8.1% over the past three months.

GenVec also licensed the rights to develop and commercialize the vaccine technology to Sanofi SA's (SNY) Merial animal health division.

The Agriculture Department issued the conditional license to Antelope Valley Bios Inc., which manufactured the vaccine under a contract with GenVec.

"This achievement demonstrates GenVec's ability to bring its technology through the regulatory review process and validates the utility of our core technology to make effective genetic vaccines," said Bryan Butman, head of GenVec's foot-and-mouth disease program. The vaccine was developed in collaboration with a branch of the government's Plum Island Animal Disease Center.

Under the conditional license, the vaccine may be distributed with the authorization of federal emergency management officials within the Agriculture Department in the event of an emergency, limited market or other special circumstances.

Write to Tess Stynes at

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V:us D:20180420 16:25:06